HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LUYE PHARMA

2.160

+0.0150.70%

Volume:88.27M

Turnover:194.02M

Market Cap:8.63B

PE:11.65

High:2.315

Open:2.210

Low:2.150

Close:2.145

52wk High:3.940

52wk Low:1.730

Shares:4.00B

HK Float Shares:4.00B

Volume Ratio:2.51

T/O Rate:2.21%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.185

ROE:4.14%

ROA:2.44%

PB:0.46

PE(LYR):11.65

PS:1.17

Loading ...

Overview Company News Filings

Luye Pharma plans USD-denominated convertible bond issue alongside repurchase of US$ 180 million 6.25% convertibles due 2028

Luye Pharma Schedules 26 June 2026 AGM; Proposes Director Re-elections, 20% Issuance Mandate and 10% Share Buyback

Bulletin Express

Luye Pharma announces annual general meeting

Shandong Boan Bio submits US FDA BLA for two denosumab biosimilars

Shandong Boan Biotechnology announces annual shareholder meeting

Shandong Boan Biotechnology launches share buyback program worth up to HK$ 200 million

Luye Pharma Reports Stable Share Capital and No Equity Movements in April 2026

Bulletin Express

Luye Pharma Releases 2025 ESG Report: Governance Upgrades, Emissions Rise on Higher Steam Consumption

Bulletin Express

绿叶制药(02186)2025年年报：营收63.084亿元，净利同比增9.4%，深耕四大治疗领域

Bulletin Express

Shandong Boan Biotech publishes 2025 annual report

Luye Pharma publishes 2025 annual report

Shandong Boan Bio proposes H-share restricted share unit incentive scheme

Shandong Boan says China CDE accepts Phase II trial application for BA1106-BA1104 combo in NSCLC

Luye Pharma launches first U.S. pharmacokinetic study for dual-acting VMAT2/Sigma-1R candidate LY03015

Bulletin Express

LUYE PHARMA's Innovative Drug LY03015 Enrolls First Patient in US Pharmacokinetic Bridging Study

Luye Pharma enrolls first subject in US PK bridging trial of LY03015

Luye Pharma Enrolls First Patient in Phase 2 China Trial of Alzheimer's Psychosis Drug

MT Newswires Live

CATL Reports 48.52% Surge in Q1 Net Profit to RMB 20.74 Billion

LUYE PHARMA's Innovative Drug LY03017 Enrolls First Patient in Chinese Phase II Trial for Alzheimer's Disease Psychosis

Luye Pharma initiates China Phase II trial of LY03017 targeting Alzheimer’s disease-related psychosis

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/02186/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02186","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02186\",,,,,undefined,":{"symbol":"02186","market":"HK","secType":"STK","nameCN":"LUYE PHARMA","latestPrice":2.16,"timestamp":1787299688003,"preClose":2.145,"halted":0,"volume":88265500,"delay":0,"changeRate":0.006993006993007051,"floatShares":3995000000,"shares":3995000000,"eps":0.1853285784096166,"marketStatus":"Market Closed","change":0.015,"latestTime":"08-21 16:08:08","open":2.21,"high":2.315,"low":2.15,"amount":194019102,"amplitude":0.076923,"askPrice":2.165,"askSize":129500,"bidPrice":2.16,"bidSize":268500,"shortable":3,"etf":0,"ttmEps":0.1853285784096166,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1404835200000,"exchange":"SEHK","adjPreClose":2.145,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":2.5104716350878267,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02186\",,,,,undefined,":{"symbol":"02186","floatShares":3995000000,"roa":"2.44%","roe":"4.14%","lyrEps":0.185329,"volumeRatio":2.5104716350878267,"shares":3995000000,"dividePrice":0,"high":2.315,"amplitude":0.076923,"preClose":2.145,"low":2.15,"week52Low":1.73,"pbRate":"0.46","psRate":"1.17","week52High":3.94,"institutionHeld":0,"latestPrice":2.16,"committee":0.349246,"eps":0.1853285784096166,"divideRate":0,"volume":88265500,"delay":0,"ttmEps":0.1853285784096166,"open":2.21,"prevYearClose":2.74,"prevWeekClose":2.05,"prevMonthClose":2.03,"prevQuarterClose":1.8,"fiveDayClose":2.05,"twentyDayClose":2.08,"sixtyDayClose":2.21,"earningDate":1787932800000,"dividendGrowthYears":0,"dividendGrowthRate":-0.5454545454545455,"fiveYearAvgDividendRate":0.016301903773029747},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02186\",params:#limit:5,,,undefined,":[{"date":"2026-08-29","symbol":"02186","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787967000000,"name":null,"time":"","dateTimestamp":1787932800000,"actualEps":null},{"date":"2026-03-30","symbol":"02186","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-28","symbol":"02186","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-03-28","symbol":"02186","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post-Mkt","dateTimestamp":1743091200000,"actualEps":null},{"market":"HK","date":"2024-08-28","symbol":"02186","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1724774400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02186\",market:\"HK\",,,undefined,":[{"executeDate":"2016-10-04","recordDate":"2016-10-05","paymentDate":"2016-11-08","value":0.037,"currency":"HKD"},{"executeDate":"2017-06-15","recordDate":"2017-06-16","paymentDate":"2017-07-18","value":0.039,"currency":"HKD"},{"executeDate":"2017-10-04","recordDate":"2017-10-06","paymentDate":"2017-11-08","value":0.033,"currency":"HKD"},{"executeDate":"2018-06-13","recordDate":"2018-06-14","paymentDate":"2018-06-29","value":0.054,"currency":"HKD"},{"executeDate":"2018-06-14","recordDate":"2018-06-15","paymentDate":"2018-06-29","value":0.054,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02186\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0,"analysts":2,"updateTime":1741881600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02186\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02186","date":"2026-08-21","current":11.654975,"percent":0.312858,"low":-63.992755,"twenty":9.238478,"median":18.120156,"eighty":24.540274,"high":34.776286,"avg":6.171333,"sd":28.103937,"marketCap":8628154458},"quantilePoints":[{"date":"2021-08-27","current":16.575515,"twenty":12.344353,"median":17.519279,"eighty":20.564394,"marketCap":14094661451},{"date":"2021-09-03","current":22.044638,"twenty":12.40055,"median":17.708697,"eighty":21.185788,"marketCap":14696694729},{"date":"2021-09-10","current":21.988087,"twenty":12.40123,"median":17.883004,"eighty":21.470564,"marketCap":14696694729},{"date":"2021-09-17","current":21.84075,"twenty":12.414001,"median":18.228288,"eighty":21.631882,"marketCap":14555039840},{"date":"2021-09-24","current":21.511954,"twenty":12.481145,"median":18.239182,"eighty":21.635962,"marketCap":14342557507},{"date":"2021-09-30","current":21.546081,"twenty":12.530388,"median":18.704574,"eighty":21.588728,"marketCap":14413384951},{"date":"2021-10-08","current":20.752947,"twenty":12.589992,"median":18.895204,"eighty":21.588728,"marketCap":13882179118},{"date":"2021-10-15","current":20.685817,"twenty":12.651449,"median":18.949177,"eighty":21.554407,"marketCap":13846765395},{"date":"2021-10-22","current":20.485831,"twenty":12.730238,"median":19.083582,"eighty":21.53243,"marketCap":13811351673},{"date":"2021-10-29","current":19.536111,"twenty":12.803367,"median":19.101273,"eighty":21.511629,"marketCap":13138490951},{"date":"2021-11-05","current":18.820545,"twenty":12.86375,"median":19.083582,"eighty":21.49491,"marketCap":12678112561},{"date":"2021-11-12","current":19.738022,"twenty":12.894227,"median":19.091238,"eighty":21.46074,"marketCap":13350973284},{"date":"2021-11-19","current":19.661131,"twenty":13.00421,"median":19.137811,"eighty":21.445158,"marketCap":13280145840},{"date":"2021-11-26","current":19.602429,"twenty":13.169475,"median":19.273651,"eighty":21.41844,"marketCap":13244732117},{"date":"2021-12-03","current":19.043091,"twenty":13.256377,"median":19.205637,"eighty":21.356333,"marketCap":12890594895},{"date":"2021-12-10","current":19.167312,"twenty":13.302953,"median":19.158816,"eighty":21.318882,"marketCap":12996836062},{"date":"2021-12-17","current":18.135308,"twenty":13.368024,"median":19.109136,"eighty":21.307971,"marketCap":12288561617},{"date":"2021-12-24","current":18.170218,"twenty":13.448397,"median":19.086323,"eighty":21.287054,"marketCap":12323975339},{"date":"2021-12-31","current":18.547579,"twenty":13.529533,"median":19.062904,"eighty":21.268362,"marketCap":12607285117},{"date":"2022-01-07","current":18.56597,"twenty":18.375946,"median":18.56597,"eighty":19.121269,"marketCap":12571871395},{"date":"2022-01-14","current":19.360579,"twenty":18.50263,"median":18.955593,"eighty":19.360316,"marketCap":13138490951},{"date":"2022-01-21","current":19.316358,"twenty":18.558614,"median":19.241881,"eighty":19.461865,"marketCap":13138490951},{"date":"2022-01-28","current":17.330031,"twenty":18.375946,"median":19.020784,"eighty":19.396668,"marketCap":11757355783},{"date":"2022-02-04","current":18.017448,"twenty":18.225477,"median":18.955593,"eighty":19.360579,"marketCap":12217734172},{"date":"2022-02-11","current":17.824772,"twenty":18.213823,"median":18.56597,"eighty":19.36014,"marketCap":12111493006},{"date":"2022-02-18","current":17.737656,"twenty":17.971349,"median":18.519614,"eighty":19.316358,"marketCap":12111493006},{"date":"2022-02-25","current":16.555822,"twenty":17.763854,"median":18.333888,"eighty":19.270476,"marketCap":11332391116},{"date":"2022-03-04","current":16.290896,"twenty":17.48519,"median":18.238205,"eighty":19.241881,"marketCap":11155322505},{"date":"2022-03-11","current":15.797577,"twenty":16.679848,"median":18.073738,"eighty":19.144102,"marketCap":10801185283},{"date":"2022-03-18","current":16.068829,"twenty":16.290896,"median":17.994399,"eighty":19.031964,"marketCap":10942840172},{"date":"2022-03-25","current":15.44415,"twenty":16.068829,"median":17.824772,"eighty":19.009604,"marketCap":10517875505},{"date":"2022-04-01","current":-61.849098,"twenty":15.797577,"median":17.750755,"eighty":18.901581,"marketCap":10234565727},{"date":"2022-04-08","current":-59.041373,"twenty":15.448043,"median":17.702918,"eighty":18.765996,"marketCap":9774187338},{"date":"2022-04-14","current":-56.996468,"twenty":14.913961,"median":17.407611,"eighty":18.632422,"marketCap":9420050115},{"date":"2022-04-22","current":-56.116914,"twenty":-27.690639,"median":17.136031,"eighty":18.558614,"marketCap":9101326615},{"date":"2022-04-29","current":-54.815619,"twenty":-54.947667,"median":16.555822,"eighty":18.544224,"marketCap":8747189393},{"date":"2022-05-06","current":-51.246645,"twenty":-54.780372,"median":16.29974,"eighty":18.531361,"marketCap":8109742392},{"date":"2022-05-13","current":-53.091722,"twenty":-54.639384,"median":16.265253,"eighty":18.500037,"marketCap":8251397281},{"date":"2022-05-20","current":-55.503031,"twenty":-54.815619,"median":16.122832,"eighty":18.435207,"marketCap":8747189393},{"date":"2022-05-27","current":-53.877947,"twenty":-54.768811,"median":15.84277,"eighty":18.333888,"marketCap":8483712836},{"date":"2022-06-02","current":-52.469187,"twenty":-54.826082,"median":15.797577,"eighty":18.296422,"marketCap":8306229304},{"date":"2022-06-10","current":-56.887727,"twenty":-54.947435,"median":15.477741,"eighty":18.258157,"marketCap":8945170020},{"date":"2022-06-17","current":-55.142227,"twenty":-55.07656,"median":15.31769,"eighty":18.230568,"marketCap":8661196368},{"date":"2022-06-24","current":-60.325872,"twenty":-55.298254,"median":14.597565,"eighty":18.216154,"marketCap":9513117323},{"date":"2022-06-30","current":-58.175065,"twenty":-55.635372,"median":-18.74027,"eighty":18.129772,"marketCap":9158150258},{"date":"2022-07-08","current":-56.313217,"twenty":-55.855846,"median":-51.770881,"eighty":18.050855,"marketCap":8874176607},{"date":"2022-07-15","current":-55.021108,"twenty":-55.968562,"median":-52.520527,"eighty":18.024708,"marketCap":8590202956},{"date":"2022-07-22","current":-56.575512,"twenty":-56.165988,"median":-52.714201,"eighty":17.989789,"marketCap":8838679901},{"date":"2022-07-29","current":-53.329509,"twenty":-56.269046,"median":-52.99078,"eighty":17.908069,"marketCap":8341726011},{"date":"2022-08-05","current":-52.555635,"twenty":-56.165988,"median":-52.714201,"eighty":17.841216,"marketCap":8199739185},{"date":"2022-08-12","current":-52.938518,"twenty":-55.994083,"median":-52.706728,"eighty":17.822883,"marketCap":8270732598},{"date":"2022-08-19","current":-52.326261,"twenty":-55.886675,"median":-52.642646,"eighty":17.786962,"marketCap":8093249066},{"date":"2022-08-26","current":-52.9756,"twenty":-55.863695,"median":-52.660685,"eighty":17.748135,"marketCap":8128745772},{"date":"2022-09-02","current":-31.343624,"twenty":-55.855846,"median":-52.571866,"eighty":17.726975,"marketCap":7986758946},{"date":"2022-09-09","current":-31.183729,"twenty":-55.841407,"median":-52.49526,"eighty":17.699531,"marketCap":7915765533},{"date":"2022-09-16","current":-30.345431,"twenty":-55.757394,"median":-52.423058,"eighty":17.605665,"marketCap":7631791882},{"date":"2022-09-23","current":-31.946695,"twenty":-55.637992,"median":-52.117175,"eighty":17.423126,"marketCap":7880268827},{"date":"2022-09-30","current":-31.311264,"twenty":-55.613106,"median":-51.844024,"eighty":17.326339,"marketCap":7738282001},{"date":"2022-10-07","current":-30.307598,"twenty":-55.58268,"median":-51.746811,"eighty":17.246893,"marketCap":7489805056},{"date":"2022-10-14","current":-30.922865,"twenty":-55.551113,"median":-51.246645,"eighty":16.896978,"marketCap":7560798469},{"date":"2022-10-21","current":-30.84373,"twenty":-55.481312,"median":-50.34254,"eighty":16.655043,"marketCap":7489805056},{"date":"2022-10-28","current":-28.260914,"twenty":-55.368276,"median":-32.563125,"eighty":16.543964,"marketCap":6850864340},{"date":"2022-11-04","current":-31.614025,"twenty":-55.26032,"median":-31.948159,"eighty":16.457174,"marketCap":7738282001},{"date":"2022-11-11","current":-33.634581,"twenty":-55.242408,"median":-32.563125,"eighty":16.297971,"marketCap":8306229304},{"date":"2022-11-18","current":-45.721428,"twenty":-55.207485,"median":-33.22245,"eighty":16.285767,"marketCap":11252455938},{"date":"2022-11-25","current":-43.760901,"twenty":-55.141563,"median":-33.367635,"eighty":16.260255,"marketCap":10684508635},{"date":"2022-12-02","current":-44.447639,"twenty":-55.136165,"median":-37.282152,"eighty":16.227576,"marketCap":11039475699},{"date":"2022-12-09","current":-48.853091,"twenty":-55.118659,"median":-42.39268,"eighty":16.155233,"marketCap":12246363718},{"date":"2022-12-16","current":-49.25118,"twenty":-55.086887,"median":-43.340977,"eighty":16.052878,"marketCap":12317357131},{"date":"2022-12-23","current":-53.634438,"twenty":-55.058661,"median":-43.835946,"eighty":15.959814,"marketCap":13417755030},{"date":"2022-12-30","current":-51.308401,"twenty":-55.041439,"median":-44.005349,"eighty":15.872031,"marketCap":12991794553},{"date":"2023-01-06","current":-51.20293,"twenty":-55.026944,"median":-44.394421,"eighty":15.829724,"marketCap":13098284672},{"date":"2023-01-13","current":-55.688351,"twenty":-55.04718,"median":-44.988741,"eighty":15.806957,"marketCap":14518152929},{"date":"2023-01-20","current":-50.814254,"twenty":-55.075644,"median":-45.997814,"eighty":15.625085,"marketCap":13133781379},{"date":"2023-01-27","current":-52.726168,"twenty":-55.064401,"median":-47.324925,"eighty":15.51009,"marketCap":13630735269},{"date":"2023-02-03","current":-59.967559,"twenty":-55.125197,"median":-48.612637,"eighty":15.506466,"marketCap":15583054122},{"date":"2023-02-10","current":-54.145898,"twenty":-55.223799,"median":-49.067721,"eighty":15.449016,"marketCap":13985702333},{"date":"2023-02-17","current":-50.223305,"twenty":-55.24706,"median":-50.022828,"eighty":15.44415,"marketCap":12849807727},{"date":"2023-02-24","current":-53.435043,"twenty":-55.223799,"median":-50.568855,"eighty":15.31769,"marketCap":13504397608},{"date":"2023-03-03","current":-53.684253,"twenty":-55.142227,"median":-50.80749,"eighty":14.984611,"marketCap":13654864434},{"date":"2023-03-10","current":-50.95465,"twenty":-51.431419,"median":-51.25263,"eighty":-51.073842,"marketCap":12864913599},{"date":"2023-03-17","current":-51.794429,"twenty":7.941044,"median":12.608551,"eighty":19.031964,"marketCap":13203463956},{"date":"2023-03-24","current":-50.622967,"twenty":7.885177,"median":12.580732,"eighty":18.926842,"marketCap":13052997131},{"date":"2023-03-31","current":19.817187,"twenty":7.821283,"median":12.572426,"eighty":18.900344,"marketCap":13692481140},{"date":"2023-04-06","current":20.265802,"twenty":7.824625,"median":12.576691,"eighty":18.904995,"marketCap":13993414791},{"date":"2023-04-14","current":21.769689,"twenty":7.817941,"median":12.568161,"eighty":18.895398,"marketCap":15046682572},{"date":"2023-04-21","current":21.127467,"twenty":7.817941,"median":12.568161,"eighty":18.895398,"marketCap":14595282094},{"date":"2023-04-28","current":21.121377,"twenty":7.817941,"median":12.568161,"eighty":18.895398,"marketCap":14482431975},{"date":"2023-05-05","current":21.634508,"twenty":7.817941,"median":12.568161,"eighty":18.895398,"marketCap":14858599039},{"date":"2023-05-12","current":19.854245,"twenty":7.817941,"median":12.568161,"eighty":18.895398,"marketCap":13542014314},{"date":"2023-05-19","current":19.466163,"twenty":7.817941,"median":12.568161,"eighty":18.895398,"marketCap":13090613837},{"date":"2023-05-25","current":19.378091,"twenty":7.821283,"median":12.572426,"eighty":18.900344,"marketCap":12977763718},{"date":"2023-06-02","current":18.99315,"twenty":7.817941,"median":12.568161,"eighty":18.895009,"marketCap":12676830066},{"date":"2023-06-09","current":20.14941,"twenty":7.817941,"median":12.568161,"eighty":18.870199,"marketCap":13429164195},{"date":"2023-06-16","current":20.87021,"twenty":7.817941,"median":12.568161,"eighty":18.870199,"marketCap":13842947966},{"date":"2023-06-23","current":21.383831,"twenty":7.817941,"median":12.568161,"eighty":18.870199,"marketCap":14106264911},{"date":"2023-06-30","current":19.04709,"twenty":7.817941,"median":12.568161,"eighty":18.870199,"marketCap":12451129828},{"date":"2023-07-07","current":19.603229,"twenty":7.821283,"median":12.572426,"eighty":18.868068,"marketCap":12789680186},{"date":"2023-07-14","current":20.469129,"twenty":7.821283,"median":12.572426,"eighty":18.868068,"marketCap":13542014314},{"date":"2023-07-21","current":20.450456,"twenty":7.821283,"median":12.572426,"eighty":18.868068,"marketCap":13466780901},{"date":"2023-07-28","current":20.815481,"twenty":7.821283,"median":12.572426,"eighty":18.868068,"marketCap":13692481140},{"date":"2023-08-04","current":19.239495,"twenty":7.784336,"median":12.560094,"eighty":18.862518,"marketCap":12676830066},{"date":"2023-08-07","current":18.3896,"twenty":7.784336,"median":12.560094,"eighty":18.843804,"marketCap":12074962764},{"date":"2023-08-18","current":17.175126,"twenty":7.649914,"median":12.545303,"eighty":18.725694,"marketCap":11172161809},{"date":"2023-08-25","current":17.108852,"twenty":7.649914,"median":12.545303,"eighty":18.56597,"marketCap":11134545103},{"date":"2023-09-01","current":21.901584,"twenty":7.649914,"median":12.545303,"eighty":18.668653,"marketCap":10833611451},{"date":"2023-09-08","current":21.623822,"twenty":7.649914,"median":12.545303,"eighty":18.733045,"marketCap":10570294506},{"date":"2023-09-15","current":25.580945,"twenty":7.649914,"median":12.545303,"eighty":18.861291,"marketCap":12601596654},{"date":"2023-09-22","current":26.536944,"twenty":7.649914,"median":12.545303,"eighty":18.895009,"marketCap":13015380424},{"date":"2023-09-29","current":26.874335,"twenty":7.683519,"median":12.547209,"eighty":18.938856,"marketCap":13203463956},{"date":"2023-10-06","current":25.814786,"twenty":7.683519,"median":12.547209,"eighty":19.018104,"marketCap":12676830066},{"date":"2023-10-13","current":27.157583,"twenty":7.683519,"median":12.547209,"eighty":19.081469,"marketCap":13316314076},{"date":"2023-10-20","current":26.20064,"twenty":7.717125,"median":12.549618,"eighty":19.107335,"marketCap":12827296892},{"date":"2023-10-27","current":27.826107,"twenty":7.683519,"median":12.547209,"eighty":19.163914,"marketCap":13617247727},{"date":"2023-11-03","current":29.285699,"twenty":7.683519,"median":12.547209,"eighty":19.24546,"marketCap":14369581856},{"date":"2023-11-10","current":29.06178,"twenty":7.683519,"median":12.547209,"eighty":19.300618,"marketCap":14256731736},{"date":"2023-11-17","current":29.561963,"twenty":7.683519,"median":12.547209,"eighty":19.374589,"marketCap":14632898801},{"date":"2023-11-24","current":29.546702,"twenty":7.683519,"median":12.547209,"eighty":19.439059,"marketCap":14745748920},{"date":"2023-12-01","current":29.049375,"twenty":7.683519,"median":12.547209,"eighty":19.488674,"marketCap":14557665388},{"date":"2023-12-08","current":28.338219,"twenty":7.683519,"median":12.547209,"eighty":19.512251,"marketCap":14143881617},{"date":"2023-12-15","current":27.875777,"twenty":7.683519,"median":12.547209,"eighty":19.600633,"marketCap":13993414791},{"date":"2023-12-22","current":26.24474,"twenty":7.683519,"median":12.547209,"eighty":19.669682,"marketCap":13165847250},{"date":"2023-12-29","current":27.821056,"twenty":7.683519,"median":12.552026,"eighty":19.688854,"marketCap":14031031498},{"date":"2024-01-05","current":26.74167,"twenty":7.683519,"median":12.568161,"eighty":19.71254,"marketCap":13391547489},{"date":"2024-01-12","current":24.700361,"twenty":7.683519,"median":12.568161,"eighty":19.750331,"marketCap":12375896415},{"date":"2024-01-19","current":23.381088,"twenty":7.683519,"median":12.568161,"eighty":19.781722,"marketCap":11698795699},{"date":"2024-01-26","current":22.113906,"twenty":7.683519,"median":12.568161,"eighty":19.859919,"marketCap":11021694983},{"date":"2024-02-02","current":18.892608,"twenty":7.683519,"median":12.568161,"eighty":19.884501,"marketCap":9404176607},{"date":"2024-02-09","current":19.176023,"twenty":7.784336,"median":12.578245,"eighty":19.874848,"marketCap":9592260139},{"date":"2024-02-16","current":20.750739,"twenty":7.717125,"median":12.572426,"eighty":19.906639,"marketCap":10382210974},{"date":"2024-02-23","current":20.785127,"twenty":7.717125,"median":12.572426,"eighty":19.960774,"marketCap":10344594268},{"date":"2024-03-01","current":21.905199,"twenty":7.75073,"median":12.576691,"eighty":20.013258,"marketCap":10908844864},{"date":"2024-03-08","current":21.140446,"twenty":7.75073,"median":12.576691,"eighty":20.070715,"marketCap":10532677800},{"date":"2024-03-15","current":23.123957,"twenty":7.75073,"median":12.576691,"eighty":20.160906,"marketCap":11510712167},{"date":"2024-03-22","current":22.388751,"twenty":7.75073,"median":12.576691,"eighty":20.239496,"marketCap":11134545103},{"date":"2024-03-28","current":20.71534,"twenty":7.75073,"median":12.576691,"eighty":20.300251,"marketCap":10269360855},{"date":"2024-04-05","current":17.490753,"twenty":7.649914,"median":12.560094,"eighty":20.327499,"marketCap":10081277323},{"date":"2024-04-12","current":17.87219,"twenty":7.683519,"median":12.568161,"eighty":20.318416,"marketCap":10306977561},{"date":"2024-04-19","current":17.038784,"twenty":7.683519,"median":12.568161,"eighty":20.318416,"marketCap":9817960378},{"date":"2024-04-26","current":17.778815,"twenty":7.75073,"median":12.576691,"eighty":20.300251,"marketCap":10231744148},{"date":"2024-05-03","current":19.753368,"twenty":7.75073,"median":12.576691,"eighty":20.300251,"marketCap":11360245341},{"date":"2024-05-10","current":19.902344,"twenty":7.75073,"median":12.576691,"eighty":20.300251,"marketCap":11473095461},{"date":"2024-05-17","current":19.539502,"twenty":7.75073,"median":12.576691,"eighty":20.300251,"marketCap":11247395222},{"date":"2024-05-24","current":17.422759,"twenty":7.75073,"median":12.576691,"eighty":20.300251,"marketCap":10006043910},{"date":"2024-05-31","current":17.535909,"twenty":7.75073,"median":12.576691,"eighty":20.300251,"marketCap":10081277323},{"date":"2024-06-07","current":18.671417,"twenty":7.75073,"median":12.584764,"eighty":20.300251,"marketCap":10720761332},{"date":"2024-06-14","current":19.01641,"twenty":7.75073,"median":12.61484,"eighty":20.300251,"marketCap":10908844864},{"date":"2024-06-21","current":18.662035,"twenty":7.75073,"median":12.64343,"eighty":20.300251,"marketCap":10683144626},{"date":"2024-06-28","current":17.749439,"twenty":7.75073,"median":12.677597,"eighty":20.300251,"marketCap":10156510736},{"date":"2024-07-05","current":19.134107,"twenty":7.75073,"median":12.678889,"eighty":20.300251,"marketCap":10946461571},{"date":"2024-07-12","current":18.843415,"twenty":7.75073,"median":12.705668,"eighty":20.300251,"marketCap":10795994745},{"date":"2024-07-19","current":18.514786,"twenty":7.75073,"median":12.720632,"eighty":20.300251,"marketCap":10607911213},{"date":"2024-07-26","current":18.119195,"twenty":7.75073,"median":12.720632,"eighty":20.300251,"marketCap":10419827681},{"date":"2024-08-02","current":18.19521,"twenty":7.75073,"median":12.720632,"eighty":20.300251,"marketCap":10457444387},{"date":"2024-08-09","current":19.115018,"twenty":7.75073,"median":12.775508,"eighty":20.300251,"marketCap":11059311690},{"date":"2024-08-16","current":18.912618,"twenty":7.75073,"median":12.858146,"eighty":20.300251,"marketCap":10946461571},{"date":"2024-08-23","current":17.926962,"twenty":7.75073,"median":12.900133,"eighty":20.300251,"marketCap":10419827681},{"date":"2024-08-30","current":13.554197,"twenty":7.75073,"median":12.932467,"eighty":20.300251,"marketCap":11473095461},{"date":"2024-09-06","current":13.547673,"twenty":7.75073,"median":13.277151,"eighty":20.300251,"marketCap":11473095461},{"date":"2024-09-13","current":13.137877,"twenty":7.75073,"median":13.326951,"eighty":20.300251,"marketCap":11096928396},{"date":"2024-09-20","current":13.369448,"twenty":7.717125,"median":13.366162,"eighty":20.309334,"marketCap":11360245341},{"date":"2024-09-27","current":14.521665,"twenty":7.717125,"median":13.391351,"eighty":20.309334,"marketCap":12413513121},{"date":"2024-10-04","current":14.98578,"twenty":7.717125,"median":13.501663,"eighty":20.309334,"marketCap":12752063479},{"date":"2024-10-10","current":14.549519,"twenty":7.75073,"median":13.581753,"eighty":20.300251,"marketCap":12300663002},{"date":"2024-10-18","current":14.312691,"twenty":7.717125,"median":13.729297,"eighty":20.309334,"marketCap":12037346057},{"date":"2024-10-25","current":13.687379,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":11510712167},{"date":"2024-11-01","current":12.650062,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":10645527919},{"date":"2024-11-08","current":12.836724,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":10720761332},{"date":"2024-11-15","current":12.117566,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":10043660616},{"date":"2024-11-22","current":11.57844,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":9592260139},{"date":"2024-11-29","current":11.449902,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":9479410020},{"date":"2024-12-06","current":11.158132,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":9216093075},{"date":"2024-12-13","current":10.769497,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":8877542717},{"date":"2024-12-20","current":9.809025,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":8049975176},{"date":"2024-12-27","current":10.091874,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":8275675414},{"date":"2025-01-03","current":9.715385,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":7974741763},{"date":"2025-01-10","current":9.430325,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":7711424818},{"date":"2025-01-17","current":9.238863,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":7560957992},{"date":"2025-01-24","current":9.501081,"twenty":7.717125,"median":13.773525,"eighty":20.309334,"marketCap":7824274937},{"date":"2025-01-28","current":9.451549,"twenty":7.75073,"median":13.731238,"eighty":20.300251,"marketCap":7824274937},{"date":"2025-02-07","current":9.962316,"twenty":7.683519,"median":13.815812,"eighty":20.318416,"marketCap":8200442001},{"date":"2025-02-14","current":10.378606,"twenty":7.683519,"median":13.815812,"eighty":20.318416,"marketCap":8538992359},{"date":"2025-02-21","current":10.888418,"twenty":7.683519,"median":13.815812,"eighty":20.318416,"marketCap":8990392836},{"date":"2025-02-28","current":10.695877,"twenty":7.683519,"median":13.815812,"eighty":20.318416,"marketCap":8802309304},{"date":"2025-03-07","current":10.835209,"twenty":7.649914,"median":13.818505,"eighty":20.327499,"marketCap":8952776130},{"date":"2025-03-14","current":10.831269,"twenty":7.649914,"median":13.818505,"eighty":20.327499,"marketCap":8952776130},{"date":"2025-03-21","current":10.653413,"twenty":7.649914,"median":13.818505,"eighty":20.327499,"marketCap":8802309304},{"date":"2025-03-28","current":11.313691,"twenty":7.649914,"median":13.818505,"eighty":20.327499,"marketCap":9328943194},{"date":"2025-04-03","current":15.89667,"twenty":7.649914,"median":13.90027,"eighty":20.327499,"marketCap":8012358469},{"date":"2025-04-11","current":13.673907,"twenty":7.649914,"median":13.90027,"eighty":20.327499,"marketCap":6846240570},{"date":"2025-04-17","current":14.315746,"twenty":7.704132,"median":13.991864,"eighty":20.318416,"marketCap":7184790928},{"date":"2025-04-25","current":14.977375,"twenty":7.620461,"median":14.315746,"eighty":20.334865,"marketCap":7523341286},{"date":"2025-05-02","current":15.543432,"twenty":7.649914,"median":14.431491,"eighty":20.327499,"marketCap":7824274937},{"date":"2025-05-09","current":14.470385,"twenty":8.080377,"median":14.518899,"eighty":20.334865,"marketCap":7335257753},{"date":"2025-05-16","current":14.279515,"twenty":8.080377,"median":14.521665,"eighty":20.334865,"marketCap":7297641047},{"date":"2025-05-23","current":16.218358,"twenty":8.080377,"median":14.614025,"eighty":20.334865,"marketCap":8313292121},{"date":"2025-05-30","current":18.412382,"twenty":8.102757,"median":14.807987,"eighty":20.334865,"marketCap":9479410020},{"date":"2025-06-06","current":21.426448,"twenty":8.102757,"median":14.984611,"eighty":20.407121,"marketCap":11059311690},{"date":"2025-06-13","current":28.557305,"twenty":8.102757,"median":15.098574,"eighty":20.491818,"marketCap":14745748920},{"date":"2025-06-20","current":24.233789,"twenty":8.102757,"median":15.322594,"eighty":20.620576,"marketCap":12488746534},{"date":"2025-06-27","current":25.476326,"twenty":8.114228,"median":15.477741,"eighty":20.681106,"marketCap":13165847250},{"date":"2025-07-04","current":25.6207,"twenty":8.114228,"median":15.720165,"eighty":20.704826,"marketCap":13241080663},{"date":"2025-07-11","current":24.626502,"twenty":8.114228,"median":15.984177,"eighty":20.752947,"marketCap":12714446773},{"date":"2025-07-18","current":27.708314,"twenty":8.114228,"median":16.236156,"eighty":20.815481,"marketCap":14294348443},{"date":"2025-07-25","current":28.915658,"twenty":8.114228,"median":16.297296,"eighty":20.978631,"marketCap":14971449159},{"date":"2025-08-01","current":28.876125,"twenty":8.114228,"median":16.565669,"eighty":21.086799,"marketCap":14858599039},{"date":"2025-08-08","current":28.452835,"twenty":8.114228,"median":16.730499,"eighty":21.140446,"marketCap":14677412984},{"date":"2025-08-15","current":27.907996,"twenty":8.114228,"median":16.892792,"eighty":21.192285,"marketCap":14374785912},{"date":"2025-08-22","current":28.163318,"twenty":8.114228,"median":16.973871,"eighty":21.241764,"marketCap":14460806856},{"date":"2025-08-29","current":27.134842,"twenty":8.114228,"median":17.109161,"eighty":21.290823,"marketCap":13999237833},{"date":"2025-09-05","current":33.994699,"twenty":8.114228,"median":17.308589,"eighty":21.365537,"marketCap":14738086497},{"date":"2025-09-12","current":33.569591,"twenty":8.114228,"median":17.373051,"eighty":21.446005,"marketCap":14579983228},{"date":"2025-09-19","current":32.396952,"twenty":8.114228,"median":17.465412,"eighty":21.511954,"marketCap":14060696154},{"date":"2025-09-26","current":30.082046,"twenty":8.114228,"median":17.556079,"eighty":21.559958,"marketCap":13022122006},{"date":"2025-10-03","current":32.035665,"twenty":8.128159,"median":17.648088,"eighty":21.622914,"marketCap":13900915516},{"date":"2025-10-10","current":31.437079,"twenty":8.114228,"median":17.689584,"eighty":21.662389,"marketCap":13621299399},{"date":"2025-10-17","current":30.169893,"twenty":8.114228,"median":17.718179,"eighty":21.693964,"marketCap":13062067166},{"date":"2025-10-24","current":28.498802,"twenty":8.114228,"median":17.771335,"eighty":21.729324,"marketCap":12343054294},{"date":"2025-10-31","current":28.916818,"twenty":8.114228,"median":17.823197,"eighty":21.769689,"marketCap":12542780092},{"date":"2025-11-07","current":28.105548,"twenty":8.114228,"median":17.862837,"eighty":21.813766,"marketCap":12183273656},{"date":"2025-11-14","current":29.220688,"twenty":8.114228,"median":17.915657,"eighty":21.900848,"marketCap":12702560730},{"date":"2025-11-21","current":27.211808,"twenty":8.114228,"median":17.96853,"eighty":22.039527,"marketCap":11823767220},{"date":"2025-11-28","current":28.212512,"twenty":8.114228,"median":18.014605,"eighty":22.096,"marketCap":12303109135},{"date":"2025-12-05","current":27.523998,"twenty":8.114228,"median":18.067029,"eighty":22.261048,"marketCap":12023493018},{"date":"2025-12-12","current":26.83427,"twenty":8.114228,"median":18.128213,"eighty":22.343397,"marketCap":11743876901},{"date":"2025-12-19","current":26.224826,"twenty":8.114228,"median":18.205594,"eighty":22.434457,"marketCap":11504205944},{"date":"2025-12-24","current":25.689515,"twenty":8.114228,"median":18.226883,"eighty":22.496241,"marketCap":11304480146},{"date":"2026-01-02","current":25.046288,"twenty":8.102757,"median":18.259725,"eighty":22.550722,"marketCap":11064809189},{"date":"2026-01-09","current":27.238959,"twenty":8.102757,"median":18.333482,"eighty":22.758976,"marketCap":12063438178},{"date":"2026-01-16","current":26.431503,"twenty":8.662699,"median":18.381886,"eighty":23.123957,"marketCap":11743876901},{"date":"2026-01-23","current":26.366897,"twenty":8.697838,"median":18.399801,"eighty":23.388973,"marketCap":11703931742},{"date":"2026-01-30","current":24.90321,"twenty":9.238767,"median":18.449932,"eighty":24.144654,"marketCap":11104754349},{"date":"2026-02-06","current":24.482792,"twenty":9.238767,"median":18.487252,"eighty":24.316821,"marketCap":10944973711},{"date":"2026-02-13","current":23.987597,"twenty":9.238863,"median":18.51521,"eighty":24.482792,"marketCap":10785193073},{"date":"2026-02-20","current":24.111169,"twenty":9.238671,"median":18.538405,"eighty":24.489222,"marketCap":10825138232},{"date":"2026-02-27","current":22.793539,"twenty":9.238671,"median":18.569199,"eighty":24.489222,"marketCap":10345796318},{"date":"2026-03-06","current":22.446459,"twenty":9.238671,"median":18.657609,"eighty":24.489222,"marketCap":10106125361},{"date":"2026-03-13","current":21.460405,"twenty":9.238671,"median":18.670035,"eighty":24.489222,"marketCap":9706673765},{"date":"2026-03-20","current":20.921425,"twenty":9.238671,"median":18.728897,"eighty":24.489222,"marketCap":9427057649},{"date":"2026-03-27","current":21.419169,"twenty":9.238671,"median":18.785609,"eighty":24.489222,"marketCap":9626783446},{"date":"2026-04-02","current":25.827734,"twenty":9.238671,"median":18.810258,"eighty":24.519571,"marketCap":11663986582},{"date":"2026-04-10","current":15.766385,"twenty":9.238671,"median":18.777575,"eighty":24.519571,"marketCap":11184644668},{"date":"2026-04-17","current":16.153762,"twenty":9.238671,"median":18.715134,"eighty":24.519571,"marketCap":11464260785},{"date":"2026-04-24","current":15.139775,"twenty":9.238671,"median":18.667726,"eighty":24.519571,"marketCap":10745247913},{"date":"2026-04-30","current":14.455372,"twenty":9.238671,"median":18.657609,"eighty":24.519571,"marketCap":10265905999},{"date":"2026-05-08","current":14.634959,"twenty":9.238574,"median":18.56597,"eighty":24.529922,"marketCap":10425686637},{"date":"2026-05-15","current":13.142503,"twenty":9.238574,"median":18.537618,"eighty":24.529922,"marketCap":9387112489},{"date":"2026-05-22","current":12.668125,"twenty":9.238671,"median":18.50556,"eighty":24.519571,"marketCap":9027606053},{"date":"2026-05-29","current":12.121492,"twenty":9.238574,"median":18.459232,"eighty":24.529922,"marketCap":8668099618},{"date":"2026-06-05","current":10.374793,"twenty":9.238574,"median":18.423117,"eighty":24.529922,"marketCap":7429799672},{"date":"2026-06-12","current":10.549264,"twenty":9.238574,"median":18.392442,"eighty":24.529922,"marketCap":7549635151},{"date":"2026-06-18","current":11.025158,"twenty":9.238671,"median":18.362867,"eighty":24.519571,"marketCap":7909141586},{"date":"2026-06-26","current":9.960146,"twenty":9.238574,"median":18.312954,"eighty":24.529922,"marketCap":7110238396},{"date":"2026-07-03","current":11.350552,"twenty":9.238574,"median":18.259725,"eighty":24.529922,"marketCap":8108867384},{"date":"2026-07-10","current":10.748688,"twenty":9.238574,"median":18.225477,"eighty":24.529922,"marketCap":7669470629},{"date":"2026-07-17","current":11.491551,"twenty":9.238574,"median":18.170218,"eighty":24.529922,"marketCap":8228702863},{"date":"2026-07-24","current":11.600513,"twenty":9.238574,"median":18.119195,"eighty":24.529922,"marketCap":8308593182},{"date":"2026-07-31","current":11.300188,"twenty":9.238478,"median":18.120156,"eighty":24.540274,"marketCap":8108867384},{"date":"2026-08-07","current":11.833869,"twenty":9.238478,"median":18.120156,"eighty":24.540274,"marketCap":8508318979},{"date":"2026-08-14","current":11.375004,"twenty":9.238478,"median":18.120156,"eighty":24.540274,"marketCap":8188757703},{"date":"2026-08-21","current":11.958942,"twenty":9.238478,"median":18.120156,"eighty":24.540274,"marketCap":8628154458}],"updateTime":1787492847395},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02186\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640904780","title":"Luye Pharma plans USD-denominated convertible bond issue alongside repurchase of US$ 180 million 6.25% convertibles due 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904780","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904780?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:50","pubTimestamp":1780491009,"startTime":"0","endTime":"0","summary":"Luye Pharma launched a proposed issue of USD-denominated convertible bonds to institutional investors, alongside a repurchase of its US$ 180 million 6.25% convertible bonds due 2028.UBS AG Hong Kong Branch was appointed to coordinate pricing for the new convertible bond issue.Net proceeds are intended to refinance existing debt, including funding the concurrent repurchase, with remaining funds for general corporate purposes.The buyback process began with a dealer manager agreement signed on June 3, 2026 to solicit bondholder selling interest.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Luye Pharma Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL9SKN7F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","BK1583","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117782994","title":"Luye Pharma Schedules 26 June 2026 AGM; Proposes Director Re-elections, 20% Issuance Mandate and 10% Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1117782994","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117782994?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:04","pubTimestamp":1780063489,"startTime":"0","endTime":"0","summary":"Luye Pharma has issued a notice convening its Annual General Meeting (AGM) for 26 June 2026 at 15:00 in Yantai, Shandong Province, PRC. Key agenda items include: 1. Financial Statements      •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639673827","title":"Luye Pharma announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639673827","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639673827?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:03","pubTimestamp":1780063387,"startTime":"0","endTime":"0","summary":"Luye Pharma Group will hold its annual general meeting in Yantai, Shandong Province on June 26, 2026.Shareholders will vote to adopt the audited consolidated financial statements and related directors’ and auditor’s reports for the year ended Dec. 31, 2025.Resolutions include re-election of directors and authorizing the board to set director remuneration.Other items include mandates to issue up to 20% of shares, repurchase up to 10%, and extend the issuance mandate by shares bought back.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Luye Pharma Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 29, 2026, and is solely r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL4ZsVYz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1583","02186","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639624215","title":"Shandong Boan Bio submits US FDA BLA for two denosumab biosimilars","url":"https://stock-news.laohu8.com/highlight/detail?id=2639624215","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639624215?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:32","pubTimestamp":1780054334,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology submitted U.S. FDA BLAs for two denosumab biosimilars, BA6101  and BA1102 .Applications seek approval across all indications of reference drugs Prolia and Xgeva.Group cited 2025 global sales of Prolia and Xgeva of about USD 6.5 billion, including about USD 4.33 billion in the U.S.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL61054B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","BK1191","06955","BK1583","BK1606","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638685200","title":"Shandong Boan Biotechnology announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638685200","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638685200?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:53","pubTimestamp":1779889987,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology will hold its annual general meeting in Yantai, Shandong Province on June 22, 2026.Shareholders will vote on the 2025 board report, supervisors’ report, annual report, auditor reappointment, director pay, supervisor pay.Resolutions include mandates to issue up to 20% additional H shares, repurchase up to 10% of issued H shares.Meeting will also consider adopting a restricted share unit incentive scheme with a 12,446,674 H-share cap.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 27, 2026, and is solely responsible for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL54YT1C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1583","BK1191","BK1161","02186","06955"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635386657","title":"Shandong Boan Biotechnology launches share buyback program worth up to HK$ 200 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635386657","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635386657?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:53","pubTimestamp":1778680382,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology launched an open-market share buyback program of up to HKD 200 million under a repurchase mandate approved at its June 5, 2025 annual general meeting.Board cited view that current trading price undervalues intrinsic value, business prospects, or recent operating performance.Repurchased shares may be canceled, held in treasury, sold, or transferred.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL1KW16x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06955","BK1161","BK1606","BK1191","BK1583","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136842288","title":"Luye Pharma Reports Stable Share Capital and No Equity Movements in April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1136842288","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136842288?lang=en_us&edition=fundamental","pubTime":"2026-05-07 16:45","pubTimestamp":1778143516,"startTime":"0","endTime":"0","summary":"For the month ended 30 April 2026, Luye Pharma Group Ltd. reported no changes in either its authorised or issued share capital, according to the company’s monthly return filed with Hong Kong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124912963","title":"Luye Pharma Releases 2025 ESG Report: Governance Upgrades, Emissions Rise on Higher Steam Consumption","url":"https://stock-news.laohu8.com/highlight/detail?id=1124912963","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124912963?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:25","pubTimestamp":1777472751,"startTime":"0","endTime":"0","summary":"Luye Pharma (02186) has published its 10th Environmental, Social and Governance (ESG) Report, covering operations from 1 January – 31 December 2025. Key take-aways are as follows:  Strategic ESG...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111053161","title":"绿叶制药(02186)2025年年报：营收63.084亿元，净利同比增9.4%，深耕四大治疗领域","url":"https://stock-news.laohu8.com/highlight/detail?id=1111053161","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111053161?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:09","pubTimestamp":1777471740,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司（LUYE...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"绿叶制药(02186)2025年年报：营收63.084亿元，净利同比增9.4%，深耕四大治疗领域","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631320548","title":"Shandong Boan Biotech publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631320548","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631320548?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:05","pubTimestamp":1777471551,"startTime":"0","endTime":"0","summary":"Boan Biotech released annual report for year ended Dec. 31, 2025, highlighting expanded commercial footprint with five marketed biologics across oncology, metabolic disease, ophthalmology.Growth focus shifted toward new launches in second half of 2025, with dulaglutide biosimilar Boyouping cleared for China market in August 2025.Ophthalmology entry accelerated with aflibercept biosimilar Boyoujing authorized in China in November 2025 for wet AMD and diabetic macular edema.Pipeline advanced with completion of patient enrollment for China Phase 3 study of nivolumab biosimilar BA1104 in October 2025, supporting next commercialization wave.International strategy progressed with denosumab biosimilars BA6101 and BA1102 completing Phase 3 trials in US, Europe, Japan, with US BLA submissions targeted by mid-2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL29rnzs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02186","BK1583","BK1191","BK1606","06955"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631326548","title":"Luye Pharma publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631326548","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631326548?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:04","pubTimestamp":1777471487,"startTime":"0","endTime":"0","summary":"Luye Pharma annual report for year ended Dec. 31, 2025 highlighted growth driven by newer products, helped by expansion in oncology and CNS portfolios.Commercial momentum accelerated with 15 cumulative new-drug launches across multiple markets from 2021-2025, including U.S. launch of ERZOFRI in April 2025.Pipeline focus shifted toward next-generation candidates, with CNS programs LY03015 and LY03020 advancing in China studies while LY03017 secured U.S. IND clearance in November 2025.Manufacturing strategy centered on scaling global supply chain, with Germany transdermal patch site running at full capacity while “Project Miesbach 2027” added new packaging operations to double technical capacity.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDLkj2zV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002262","BK0188","LU1064131003.USD","LU1064130708.USD","BK0070","BK1191","BK1583","BK1606","LU2148510915.USD","02186","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630004773","title":"Shandong Boan Bio proposes H-share restricted share unit incentive scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2630004773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630004773?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:34","pubTimestamp":1777383250,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology proposed adopting a restricted share unit incentive scheme for its H shares.Board resolution dated April 28, 2026 outlined scheme funded by existing shares, not new share issuance.Plan requires shareholder approval via special resolutions at a general meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL2NpfZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1606","BK1191","02186","06955","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630438266","title":"Shandong Boan says China CDE accepts Phase II trial application for BA1106-BA1104 combo in NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2630438266","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630438266?lang=en_us&edition=fundamental","pubTime":"2026-04-26 18:31","pubTimestamp":1777199517,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology said China NMPA drug review center CDE accepted its Phase II clinical trial application for BA1106 combined with PD-1 inhibitor BA1104 in non-small cell lung cancer.Study targets driver gene-negative NSCLC as a first-line or second-line regimen.Boan plans to accelerate Phase II development following Phase I safety data showing mostly Grade 1-2 adverse events.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nNDL8sTkzv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","06955","BK1606","BK1191","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100840496","title":"Luye Pharma launches first U.S. pharmacokinetic study for dual-acting VMAT2/Sigma-1R candidate LY03015","url":"https://stock-news.laohu8.com/highlight/detail?id=1100840496","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100840496?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:22","pubTimestamp":1776687761,"startTime":"0","endTime":"0","summary":"On 20 April 2026, Luye Pharma Group Ltd. disclosed the enrolment of the first volunteer in a U.S. pharmacokinetic (PK) bridging trial for LY03015, the company’s in-house-developed new molecular...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152735367","title":"LUYE PHARMA's Innovative Drug LY03015 Enrolls First Patient in US Pharmacokinetic Bridging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1152735367","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152735367?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:14","pubTimestamp":1776687286,"startTime":"0","endTime":"0","summary":"LUYE PHARMA (02186) announced that the first participant has been enrolled in the US pharmacokinetic (PK) bridging clinical trial for its self-developed new molecular entity, LY03015. This compound...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","PK","BK1574","159992","BK1583","BK1606","BK1161","06978","02186","BK1191","BK4181","03015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628228740","title":"Luye Pharma enrolls first subject in US PK bridging trial of LY03015","url":"https://stock-news.laohu8.com/highlight/detail?id=2628228740","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628228740?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:03","pubTimestamp":1776686628,"startTime":"0","endTime":"0","summary":"Luye Pharma enrolled first subject in a U.S. pharmacokinetic bridging study of LY03015, an investigational VMAT2 inhibitor and sigma-1 receptor agonist for tardive dyskinesia and Huntington’s disease.Results have not been presented; study is designed to generate safety, tolerability, and pharmacokinetic evidence to guide dose selection for planned U.S. Phase II and Phase III trials.Trial is open-label, single-dose, parallel-group in healthy Chinese and Caucasian adults, positioning LY03015 for cross-population development in U.S. regulatory pathway.Program aims to support a differentiated profile versus existing VMAT2-only therapies by combining symptom control with potential longer-lasting benefit.Luye expects to complete a Phase II trial in China soon, supporting parallel development across China and U.S. CNS pipelines.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDLbYzcr7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02186","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627268263","title":"Luye Pharma Enrolls First Patient in Phase 2 China Trial of Alzheimer's Psychosis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2627268263","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627268263?lang=en_us&edition=fundamental","pubTime":"2026-04-16 11:32","pubTimestamp":1776310364,"startTime":"0","endTime":"0","summary":"Luye Pharma  said it enrolled the first patient in a Phase 2 clinical trial in China for its investigational drug LY03017, according to a Wednesday Hong Kong bourse filing.Shares of the pharma company fell over 2% in late-morning trade Thursday.The drug is being tested for the treatment of psychosis associated with Alzheimer's disease.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","02186","BK1583","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153591250","title":"CATL Reports 48.52% Surge in Q1 Net Profit to RMB 20.74 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1153591250","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153591250?lang=en_us&edition=fundamental","pubTime":"2026-04-16 09:23","pubTimestamp":1776302616,"startTime":"0","endTime":"0","summary":"CATL (03750) plans to invest RMB 30 billion to establish a wholly-owned subsidiary for building a new energy mineral platform. Meig Smart Technology (03268) intends to invest RMB 300 million in an AI...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0797268264.HKD","LU0918141887.USD","LU0312595415.SGD","LU0441854154.USD","LU2125910849.SGD","LU0048575426.USD","LU0516423091.SGD","LU2476274308.USD","LU1719994722.HKD","LU1023057109.AUD","HK0000181138.USD","LU0320764599.SGD","LU1934453819.USD","LU0072462343.USD","LU1939255532.USD","LU0048388663.USD","BK1502","LU0823040885.USD","HK0000286598.CNH","LU0449515922.USD","BK1575","LU0611395673.USD","LU0143863198.USD","LU0261950470.USD","LU1770034418.SGD","LU0516422440.USD","LU1008478684.HKD","LU1051768304.USD","LU1861214812.USD","LU0823413587.USD","LU2275660780.HKD","LU0049853897.USD","LU1064130708.USD","00300","IE00B29SXG58.USD","LU1515016050.SGD","LU0607220059.USD","EVS.SI","LU1051769294.HKD","LU0214875030.USD","LU0531971595.HKD","LU0320764755.SGD","BK1535","LU0594300419.USD","02298","600026","LU2348774022.SGD","LU0149534421.HKD","LU2153591404.USD","LU0456846285.SGD","LU1328277881.USD","LU2399975544.HKD","LU2097828474.EUR","LU0011963245.USD","LU0650527681.SGD","LU2477742899.HKD","LU2506952337.HKD","LU2097828805.USD","LU1323998911.USD","LU0359202008.SGD","LU0165289439.USD","LU0269904917.USD","LU2087589342.USD","IE00BPRC5H50.USD","02038","08279","03268","LU0594300179.USD","LU0672654166.SGD","601898","LU0634319403.HKD","LU1282648689.USD","06656","002352","IE00B543WZ88.USD","601111","LU2039709279.SGD","LU1831875114.USD","LU1813983027.USD","02556","HK0000181112.HKD","LU1146622755.USD","LU2045819591.USD","IE0003795394.USD","LU2153592121.USD","09995","SG9999000327.SGD","LU0106252389.USD","LU0348735423.USD","LU0605514214.HKD","SGXZ49509284.SGD","LU0128522157.USD","000333","LU0405327148.USD","LU0106259558.USD","LU1152091168.USD","LU1769817096.USD","00670","LU0572944931.SGD","LU0140636845.USD","LU0047713382.USD","LU0181495838.USD","LU0823426308.USD","601995","01810","LU0244354667.USD","BK1607","LU2289578879.USD","00753","LU0124384867.USD","LU1781817850.SGD","LU1880383440.USD","02465","LU2476274720.SGD","03908","002881","IE00B8L5B284.USD","IE0032431581.USD","LU1868837565.USD","LU0048580855.USD","LU0516422366.SGD","LU0117841782.USD","XIACY","LU0700851271.USD","LU1255011170.USD","LU2506952410.USD","LU0540923850.HKD","LU2495084118.USD","HXXD.SI","01138","IE00BZ199S13.USD","LU0143863784.USD","01898","SG9999003461.SGD","LU2294711713.HKD","LU0828237510.HKD","LU0509642566.USD","LU0531970944.HKD","LU0499858602.USD","LU0821914370.USD","LU0588546209.SGD","LU2328871848.SGD","LU2506952253.HKD","LU0651947912.USD","LU1820825898.SGD","LU0823414551.USD","BK4588","LU0054450605.USD","LU0164872284.USD","LU0516423174.USD","LU1048588211.SGD","LU1105468828.SGD","IE00B5MMRT66.SGD","LU0084288322.USD","LU1769817179.HKD","BK4585","02245","BK1618","SG9999001846.SGD","LU0039217434.USD","LU0326950275.SGD","06613","LU0348805143.USD","LU1961090484.USD","LU0051755006.USD","LU0505663152.USD","LU0979878070.USD","LU1481107354.HKD","MIUmain","LU0348814723.USD","300433","603906","LU0149721374.USD","LU1152091754.HKD","LU0067412154.USD","LU1064131003.USD","LU0823437842.USD","LU0307460666.USD","BK0224","BK1116","LU1981816686.USD","LU2226246903.HKD","LU2294711473.HKD","LU1807302812.USD","06936","02186","LU0516422952.EUR","BK1610","BK1589","BK1166","LU2097828714.EUR","LU0345776255.USD","SBHMY","LU0918141705.HKD","LU2778985437.USD","LU0302445910.USD","LU2348773727.SGD","HK0000165453.HKD","LU0164880469.USD","BK1523","IE0034224299.USD","LU0192582467.USD","LU0348816934.USD","LU0456827905.SGD","LU1997245094.SGD","LU0499858438.USD","LU1997244956.HKD","LU2242644610.SGD","LU0254981946.USD","LU0231483743.USD","LU0823038988.USD","LU1102505929.USD","LU1251922891.USD","LU0871576103.HKD","LU2424517915.HKD","LU2152927971.USD","LU0211977185.USD","LU0348827113.USD","LU0107464264.USD","SG9999002463.SGD","LU2148510915.USD","LU0052750758.USD","LU0328353924.USD","LU2097828631.EUR","LU1580142542.USD","LU0228659784.USD","LU0251143458.SGD","LU0463099449.HKD","LU1997245177.USD","LU0823413660.USD","LU1861219969.SGD","LU0543330483.HKD","688331","LU1720050803.USD","LU0043850808.USD","SG9999000459.SGD","LU0501845795.SGD","LU0029875118.USD","CCOZY","LU1303224171.USD","SG9999001093.SGD","SG9999002828.SGD","LU0724618433.USD","81810","FXCNY","LU0405327494.USD","LU0259732245.USD","03750","LU0210526637.USD","LU1048596156.SGD","LU0561508036.HKD","BK1193","BK4519","LU0455707207.USD","BK4526","LU2298322129.HKD","BK1615","01177","LU1794554557.SGD","LU1242518931.SGD","LU0235996351.USD","LU0708995583.HKD","LU0359201885.HKD","LU0823414478.USD","LU1960683339.HKD","LU2580892789.USD","BK1506","LU0469268626.HKD","LU2257852520.SGD","LU0072913022.USD","LU1969619763.USD","LU0327786744.USD","LU1721428347.USD","LU0314109678.HKD","LU0188438112.USD","SG9999014674.SGD","LU1993786604.SGD","LU0326948709.USD","LU2238339852.HKD","LU0675040207.SGD","LU1242518857.USD","SG9999001903.USD","LU1039395188.USD","LU2097828557.USD","LU0823039010.USD","01093","LU2580892862.HKD","LU0593848301.USD","LU2506951792.HKD","LU1880383366.USD","LU2125910500.SGD","SG9999001689.USD","LU2360107325.USD","IE00B8HQ1Z84.USD","LU0348825331.USD","IE00B3M56506.USD","LU1979443071.USD","IE0003851619.USD","MIUmain","LU0345775950.USD","LU0823397285.USD","BK1149","LU2298064838.USD","IE00BD6J9T35.USD","600115","LU1808992512.USD","LU1956131251.USD","LU0449509016.USD","LU0880133367.SGD","LU2249611893.SGD","LU1868838027.USD","LU0828238088.HKD","LU1102505762.USD","LU1770036033.HKD","LU0417516738.SGD","LU0651946864.USD","LU0823397103.USD","LU0502904849.HKD","LU2357125470.USD","LU0828237940.HKD","300750","LU0370786039.SGD","LU0417516902.SGD","LU0823426480.USD","LU0169518387.USD","LU0823041008.USD","SGXZ81163826.USD","LU1978683503.SGD","LU2449936058.SGD","LU0164865239.USD","LU1655091616.SGD","LU0106959298.USD","LU0359201612.USD","LU1188198961.HKD","LU0132412106.USD","BK1521","LU3063872942.SGD","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130423128","title":"LUYE PHARMA's Innovative Drug LY03017 Enrolls First Patient in Chinese Phase II Trial for Alzheimer's Disease Psychosis","url":"https://stock-news.laohu8.com/highlight/detail?id=1130423128","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130423128?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:08","pubTimestamp":1776258507,"startTime":"0","endTime":"0","summary":"LUYE PHARMA has announced that the first patient has been enrolled in a Phase II clinical trial in China for its self-developed innovative drug, LY03017, which is intended for the treatment of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1583","BK1606","02186","BK1161","06978","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182767326","title":"Luye Pharma initiates China Phase II trial of LY03017 targeting Alzheimer’s disease-related psychosis","url":"https://stock-news.laohu8.com/highlight/detail?id=1182767326","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182767326?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:03","pubTimestamp":1776258208,"startTime":"0","endTime":"0","summary":"Hong Kong–listed Luye Pharma Group Ltd. enrolled the first subject in a randomized, double-blind, placebo-controlled Phase II trial of its in-house candidate LY03017 for Alzheimer’s disease-related...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":78,"code":"91000000","status":"200"}]}}